Role of Endothelial Soluble Epoxide Hydrolase in Cerebrovascular Function and Ischemic Injury

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Zhang, Wenri ^a   Davis, Catherine M ^a   Edin, Matthew L ^b   Lee, Craig R ^c   Zeldin, Darryl C ^b   Alkayed, Nabil J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c UNC Hamner Institute for Drug Safety Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; EPOXIDE HYDROLASE; SOLUBLE EPOXIDE HYDROLASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL FUNCTION; BLOOD VESSEL REACTIVITY; BRAIN BLOOD FLOW; BRAIN CIRCULATION; BRAIN DAMAGE; BRAIN FUNCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN REGION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORPUS STRIATUM; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; IN VIVO STUDY; LASER DOPPLER FLOWMETRY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; SEX DIFFERENCE; SOLUBLE EPOXIDE HYDROLASE GENE; TRANSGENE; UPREGULATION; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ANIMALS; BRAIN ISCHEMIA; CEREBRAL CORTEX; CORPUS STRIATUM; ENDOTHELIUM, VASCULAR; EPOXIDE HYDROLASES; FEMALE; GENE EXPRESSION; HUMANS; MALE; MICE; MICE, TRANSGENIC; SEX FACTORS; VASODILATION; VASODILATOR AGENTS;

MUS; MUS MUSCULUS;

EID: 84876039103     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061244     Document Type: Article

References (28)

1. Alkayed NJ, Briks EK, Hudetz AG, Roman RJ, Henderson L, et al. (1996) Inhibition of brain P-450 arachidonic acid epoxygenase decreases baseline cerebral blood flow. Am J Physiol 271: H1541-6.
2. Alkayed NJ, Goyagi T, Joh HD, Klaus J, Harder DR, et al. (2002) Neuroprotection and P450 2C11 upregulation after experimental transient ischemic attack. Stroke 33: 1677-84.
3. Gupta NC, Davis CM, Nelson JW, Young JM, Alkayed NJ, (2012) Soluble Epoxide Hydrolase: Sex Differences and Role in Endothelial Cell Survival. ATVB 32: 1936-42.
4. Harder DR, Alkayed NJ, Lange AR, Gebremedhin D, Roman RJ, (1998) Functional hyperemia in the brain: hypothesis for astrocyte-derived vasodilator metabolites. Stroke 29: 229-34.
5. Liu M, Alkayed NJ, (2005) Hypoxic preconditioning and tolerance via hypoxia inducible factor (HIF) 1alpha linked induction of P450 2C11 epoxygenase in astrocytes. J Cereb Blood Flow Metab 25: 939-48.
6. Zeldin DC, (2001) Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 276: 36059-62.
7. Zhang W, Iliff JJ, Campbell CJ, Wang RK, Hurn PD, et al. (2009) Role of soluble epoxide hydrolase in the sex-specific vascular response to cerebral ischemia. J Cereb Blood Flow Metab 29: 1475-1481.
8. Sura P, Sura R, Enayetallah AE, Grant DF, (2008) Distribution and expression of soluble epoxide hydrolase in human brain. J Histochem Cytochem 56: 551-9.
9. Appelros P, Stegmayr B, Terént A, (2010) A review on sex differences in stroke treatment and outcome. Acta Neurol Scand 121: 359-69.
10. Reeves MJ, Bushnell CD, Howard G, Gargano JW, Duncan PW, et al. (2008) Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol 7: 915-26.
11. Liu M, Kelley MH, Herson PS, Hurn PD, (2010) Neuroprotection of sex steroids. Minerva Endocrinol 35: 127-43.
12. Miller VM, Duckles SP, (2008) Vascular actions of estrogens: functional implications. Pharmacol Rev 60: 210-41.
13. Koerner IP, Jacks R, DeBarber AE, Koop D, Mao P, et al. (2007) Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury. J Neurosci 27: 4642-9.
14. Zhang W, Otsuka T, Sugo N, Ardeshiri A, Alhadid YK, et al. (2008) Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia. Stroke 39: 2073-2078.
15. Edin ML, Wang Z, Bradbury JA, Graves JP, Lih FB, et al. (2011) Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia- reperfusion injury in isolated mouse heart. FASEB J 25: 3436-2447.
16. Zhang W, Koerner IP, Noppens R, Grafe M, Tsai HJ, et al. (2007) Soluble epoxide hydrolase: a novel therapeutic in stroke. J Cereb Blood Flow Metab 27: 1931-40.
17. Lee CR, Imig JD, Edin ML, Foley J, Degraff LM, et al. (2010) Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension- induced renal injury in mice. FASEB J 24: 3370-3781.
18. Campbell WB, Fleming I, (2010) Epoxyeicosatrienoic acids and endothelium- dependent responses. Pflugers Arch 459: 881-95.
19. Panigrahy D, Edin ML, Lee CR, Huang S, Bielenberg DR, et al. (2012) Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice. J Clin Invest 122: 178-91.
20. Halcox JPJ, Nour KRA, Zalos G, Quyyumi AA, (2001) Coronary vasodilation and improvement in endothelial dysfunction with endothein ETA receptor blockade. Circ Res 89: 969-76.
21. Newton DJ, Khan F, Belch JJ, (2001) Assessement of microvascular endothelial function in human skin. Clin Sci (Lond) 101: 567-27.
22. Zhang LN, Vincelette J, Chen R, Gless RD, Anandan SK, et al. (2011) Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertension. Eur J Pharmacol 654: 68-74.
23. Campbell WB, Gebremedhin D, Pratt PF, Harder DR, (1996) Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78: 415-23.
24. Davis CM, Siler DA, Alkayed NJ, (2011) Endothelium-derived hyperpolarizing factor in the brain: influence of sex, vessel size and disease state. Womens Health (Lond Engl) 7: 293-303.
25. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, et al. (1996) Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401: 493-7.
26. Gebremedhin D, Harder DR, Pratt PF, Campbell WB, (1998) Bioassay of an endothelium-derived hyperpolarizing factor from bovine coronary arteries: role of a cytochrome P450 metabolite. J Vasc Res 35: 274-84.
27. Higashimori H, Blanco VM, Tuniki VR, Falck JR, Filosa JA, (2010) Role of epoxyeicosatrienoic acids as autocrine metabolites in glutamate-mediated K+ signaling in perivascular astrocytes. Am J Physiol Cell Physiol 299: C1068-78.
28. Iliff JJ, Wang R, Zeldin DC, Alkayed NJ, (2009) Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels. Am J Physiol Heart Circ Physiol 296: H1352-63.